Why Atropine Is Not Used for Bronchial Asthma

Atropine is contraindicated in bronchial asthma. As an anticholinergic, it blocks acetylcholine, a neurotransmitter that helps regulate airway tone. In asthma, airways are already inflamed and narrowed; atropine can worsen bronchospasm, making breathing more difficult.

Standard Asthma Treatment

Asthma is managed with medications that relax airways and reduce inflammation:

• Inhaled corticosteroids (e.g., fluticasone, budesonide) for long-term control.
• Short-acting beta-agonists (e.g., albuterol) for quick relief of bronchospasm.
• Long-acting beta-agonists (e.g., salmeterol) combined with corticosteroids for maintenance.
• Leukotriene modifiers (e.g., montelukast) to block inflammatory pathways.

Atropine has no role in acute or chronic asthma management and should be avoided in asthmatic patients.